Stem cells in regenerative medicine: science, regulation and business strategies

Content: Therapeutic stem cells answer a strategic breakthrough need of healthcare / Alain Vertes --
Ethical considerations on the research and business of stem cells / Ljiljana Minwalla --
Projected growth of the worldwide stem cell market / Ed Field --
Cell therapy manufacturing: identifying and meeting demand / Jessica Carmen, David A. Brindley, Natasha L. Davie and David Smith --
The history of stem cell transplantation / Hilliard M. Lazarus and Stan Gerson --
Regulatory and intellectual property considerations for therapeutic human stem cell-based regenerative medicine product development: a U.S. perspective / Michael Mendicino and Darin Weber --
The regulation of stem cells in the UK and EU / Alex Denoon, Julian Hitchcock and James Lawford Davies --
The business of stem cell research tools / Erik Miljan --
Stem cell-derived cardiomyocytes and hepatocytes as tools for drug development and screening applications / Kate Camerona, Howard Marriage, David Haya and Claire Medine --
Stem cell tools for compound development / Tom Novak --
Stem cell origin of cancer: prospects for functional therapeutics and regenerative medicine / Vinagolu K. Rajasekhar --
The market of stem cell medicines for domestic and high value animals / Bob J. Harmann --
Stem cells veterinary medicines: a conceptual approach / John Peroni and Lindsey Boone --
Stem cells in veterinary medicines: a practical approach / Bob J. Harmann --
Stem cell veterinary medicines as success signals towards human stem cell therapeutics / Alain Vertes --
Animal models in regenerative medicine / Andrew N. Bubak, John D. Elsworth and John R. Sladek, Jr. --
Stem cell characterization: a guide to stem cell types, technologies, and future applications / Justin Lo Re, Rezma Shrestha and Leonard Sciorra --
Stem cell value chains / Judy Muller-Cohn, Paul Diaz and Rolf Muller --
Stem cell culture processes / Ravali Raju, Shikha Sharma and Wei-Shou Hu --
Indication transformation maps and the challenge of live cells delivery / Bob Deans and Lee Babiss --
Delivery and targeting of therapeutic cells / Paul Lin, Arnold I. Caplan and Erkki Ruoshlati --
Hematopoietic stem cells / Steve Wolpe and Lynnet Koh --
MSCs: the new medicince / Arnold Caplan --
Innovation and commercialization of induced pluripotent stem cells / Shintaro Sengoku --
Embryonic stem cells / Rachel Eiges, Benjamin E. Reubinoff and Charles Irving --
Allogeneic versus autologous stem cell transplantation in regenerative medicine / Kathy Trzaska-Accurso and Pranela Rameshwar --
Clinical immunological barriers to regenerative medicine: do they matter? / Cristina Trento and Francesco Dazzi --
Challenges in the clinical development of stem cells / John Caulfield --
Pricing and reimbursement of regenerative medicines / Nathan Dowden --
The role of patient advocacy in the clinical translation of regenerative medicine / Bernard Siegel and Alan Jakimo --
Financing strategies for regenerative medicine start-ups / Carol Julie Walton, Lee Buckler and Gregory A. Bonfiglio --
Strategic alliances, mergers and acquisitions in regenerative medicine / Nafees N. Malik, Timothy E. Allsopp and Devyn M. Smith --
History of monoclonal antibodies and lessons for the development of stem cell therapeutics / Alain Vertes and Nathan Dowden --
Deployment of stem cell technologies in industry and healthcare/ Alain Vertes.